| Announce Date | 04/22/2025 |
| EPS Normalized Actual | $-3.5 (Beat by $38.5) |
| EPS GAAP Actual | $-3.5 (Beat by $38.5) |
| Revenue Actual | $0.00163718B |
| Revenue Surprise | Beat by $1.63718M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0 |
| EPS GAAP Estimate | $0 |
| Revenue Estimate | $0.001766B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | -1.69 | -1.3 | -1.69 | -1.69 | 1 |
| Dec 2028 | -0.55 | -4 | -0.55 | -0.55 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | -12.53 | -12.53 | 0.00163718B | 100% | -3.91M |
| FQ4 2024 (Dec 2024) | -9.04 | -8.98 | 0.00168597B | 100% | -3.12M |
| FQ3 2016 (Sep 2016) | -0.96 | -0.96 | 1.7831E-5B | 100% | 0.02M |
| FQ4 2016 (Dec 2016) | -1.26 | -1.26 | 9.517E-6B | 100% | 0.01M |
| FQ1 2017 (Mar 2017) | -0.98 | -0.98 | 5.224E-5B | 100% | 0.05M |
| FQ2 2017 (Jun 2017) | -0.62 | -0.62 | 8.033E-5B | 100% | 0.08M |
| FQ3 2017 (Sep 2017) | -0.67 | -0.67 | 6.822E-5B | 73.86% | 0.07M |
| FQ4 2017 (Dec 2017) | -0.91 | -0.91 | 8.1355E-5B | 88.3% | 0.08M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0
Consensus Revenue Estimates
0.001766B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0 | -- | 0 | 0 | 0 |
| FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 0 |
| FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 0 |
| FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 0 |
| FQ4 2026 (Dec 2026) | 0 | -- | 0 | 0 | 0 |
| FQ3 2026 (Sep 2026) | 0 | -- | 0 | 0 | 0 |
| FQ2 2026 (Jun 2026) | 0 | -- | 0 | 0 | 0 |
| FQ1 2026 (Mar 2026) | 0 | INF | 0 | 0 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0B | -- | 0B | 0B | 1 |
| FQ3 2027 (Sep 2027) | 0B | -- | 0B | 0B | 1 |
| FQ2 2027 (Jun 2027) | 0B | -- | 0B | 0B | 1 |
| FQ1 2027 (Mar 2027) | 0B | -- | 0B | 0B | 1 |
| FQ4 2026 (Dec 2026) | 0B | -- | 0B | 0B | 1 |
| FQ3 2026 (Sep 2026) | 0B | -- | 0B | 0B | 1 |
| FQ2 2026 (Jun 2026) | 0B | -- | 0B | 0B | 1 |
| FQ1 2026 (Mar 2026) | 0B | 7.29 | 0B | 0B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | 0 | -12.53 | -12.53 | 100% |
| FQ4 2024 (Dec 2024) | -0.06 | -9.04 | -8.98 | 99.34% |
| FQ3 2016 (Sep 2016) | -0.96 | -0.96 | 100% | |
| FQ4 2016 (Dec 2016) | -1.26 | -1.26 | 100% | |
| FQ1 2017 (Mar 2017) | -0.98 | -0.98 | 100% | |
| FQ2 2017 (Jun 2017) | -0.62 | -0.62 | 100% | |
| FQ3 2017 (Sep 2017) | -0.67 | -0.67 | 100% | |
| FQ4 2017 (Dec 2017) | -0.91 | -0.91 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2025 (Mar 2025) | $0.01B | $0B | $-3.91M | -238.74% |
| FQ4 2024 (Dec 2024) | $0B | $0B | $-3.12M | -185.17% |
| FQ3 2016 (Sep 2016) | $0B | $0B | $0.02M | 100% |
| FQ4 2016 (Dec 2016) | $0B | $0B | $0.01M | 100% |
| FQ1 2017 (Mar 2017) | $0B | $0B | $0.05M | 100% |
| FQ2 2017 (Jun 2017) | $0B | $0B | $0.08M | 100% |
| FQ3 2017 (Sep 2017) | $0B | $0B | $0.07M | 100% |
| FQ4 2017 (Dec 2017) | $0B | $0B | $0.08M | 100% |